Journal issue - WANFANG MED ONLINE

Contact US | Chinese

You Position: Home > Journal issue

Acta Pharmaceutica Sinica

Issue 1, 2022

Items 1-5 of 24

«Preious | of 5 | Next»

1

Research progress in nano-drug delivery systems for antitumor multi-drug combinational application

Acta Pharmaceutica Sinica, Volume 57, Issue 1,2022, Pages 前插1-前插6,1-12, doi:10.16438/j.0513-4870.2021-0787

2

Advances of microneedle vaccines in transcutaneous immunization

Acta Pharmaceutica Sinica, Volume 57, Issue 1,2022, Pages 142-149, doi:10.16438/j.0513-4870.2021-1297

3

Tumor microenvironment responsive liposomes blocking CXCL12/CXCR4 pathway and synergistically enhancing immune efficacy of anti-PD-L1

Acta Pharmaceutica Sinica, Volume 57, Issue 1,2022, Pages 178-187, doi:10.16438/j.0513-4870.2021-0967

4

Research progress of tumor microenvironment-responsive RNA drug delivery systems

Acta Pharmaceutica Sinica, Volume 57, Issue 1,2022, Pages 109-121, doi:10.16438/j.0513-4870.2021-1251

5

Folic acid-modified phospholipid-encapsulated paclitaxel nanocrystals for preoperative chemotherapy of gastric cancer

Acta Pharmaceutica Sinica, Volume 57, Issue 1,2022, Pages 233-241, doi:10.16438/j.0513-4870.2021-1247

Items 1-5 of 24

«Preious | of 5 | Next»

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn